Select Page

Catalyst’s Plan for Amifampridine phosphate® NDA

Robert Gadimian from www.hotbiotechstocks.com explains Catalyst’s plan for amifampridine phosphate NDA in Lambert-Eaton Myasthenic Syndrome (LEMS). Introduction Catalyst Pharmaceuticals Inc. (Nasdaq:CPRX) focuses on developing innovative therapies for people with rare...

Does Avadel Pharmaceutics Have the Potential to 10-Double?

Robert Gadimian from Hot Bio Stock (hotbiotstock.com) explains how conservative estimates point to $350 billion market cap. Robert Gadimian Mar 14, 2018 at 1:00PM Avadel Pharmaceuticals (AVDL) At present, Avadel is one of my favorite biotech stocks because of the...

Is Osmotica’s Osmolex a Threat to Adamas’ (ADMS) Gocovri?

Robert Gadimian from Hot Bio Stock (hotbiotechstocks.com) explains why the market has expressed an overreaction to the approval of Osmolex. Robert Gadmian Mar 12, 2018 at 4:00PM Osmolex, like  Adamas’ Gocovri, is an extended release form of Amantadine. This article...
Plant extract to fight skin cancer

Plant extract to fight skin cancer

Eggplant substance has amazing health benefits. PRESS RELEASE UPDATED: DEC 28, 2017 Topical Treatment derived from BEC5 found in Eggplant. Skin cancer incidence is increasing at alarming rates and is among the highest of the cancer types. The incidences of nonmelanoma...
New Drug Plumps Thinning Eyebrows

New Drug Plumps Thinning Eyebrows

Eyebrow pencil is now the ‘old school’ fix. PRESS RELEASE UPDATED: Dec 20, 2017 Los Angeles, California.  Thinning eyebrows common concern for mature women Women who suffer from thinning eyebrows will be enthused by data gained in an exploratory study for hair...